Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15

New England Journal of Medicine

Volumn 342, Issue 21, 2000, Pages 1568-1571

  Means Markwell, Melissa ^a   Burgess, Timothy ^a   DeKeratry, Dominic ^a   O'Neil, Kevin ^a   Mascola, John ^b   Fleisher, Thomas ^c   Lucey, Daniel ^d  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; INTERLEUKIN 15; INTERLEUKIN 2; PREDNISONE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; IMMUNOSTIMULATION; MALE; PERICARDIAL EFFUSION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTINEOPLASTIC AGENTS; DYSPNEA; HUMANS; HYDROXYUREA; HYPEREOSINOPHILIC SYNDROME; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; PERICARDIAL EFFUSION; PHENOTYPE; T-LYMPHOCYTES;

EID: 0034713234     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200005253422104     Document Type: Article

References (17)

1. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
2. Owen WF, Rothenberg ME, Petersen J, et al. Interleukin 5 and pheno-typically altered eosinophils in the blood of patients with the idiopathic hy pereosinophilic syndrome. J Exp Med 1989;170:343-8.
3. Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535-8.
4. Brugnoni D, Airo P, Rossi G, et al. A case of hypereosinophilic syndrome is associated with expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996;87:1416-22.
5. Simon H-U, Yousefi S, Dommann-Scherrer CC, et al. Expansion of CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996;183:1071-82.
6. Simon H-U, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-20.
7. Silberstein DS, Schoof DD, Rodrick ML, et al. Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells. J Immunol 1989;142:2162-7.
8. Schwartz DH, Skowron G, Merigan TC. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1991;4:11-23.
9. Macdonald D, Gordon AA, Kajitani H, Enokihara H, Barrett AJ. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production. Br J Haematol 1990;76:168-73.
10. Mori A, Suko M, Kaminuma O, et al. IL-15 promotes cytokine production of human T helper cells. J Immunol 1996;156:2400-5.
11. Tagaya Y, Bamford RN, DeFilippis AP, Waldman TA. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996;4:329-36.
12. Lucey DR, Pinto LA, Bethke FR, et al. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 1997;4:43-8.
13. Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol 1996;91:1789-94.
14. Zambello R, Facco M, Trentin L, et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997;89:201-11.
15. Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996;97:1373-81.
16. Carson DA. Unconventional T-cell activation by IL-15 in rheumatoid arthritis. Nat Med 1997;3:148-9.
17. Carson WE, Ross ME, Baiocchi RA, et al. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 1995;96:2578-82.